Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
about
Resveratrol in prostate diseases - a short reviewResveratrol and clinical trials: the crossroad from in vitro studies to human evidenceDietary polyphenols in prevention and treatment of prostate cancerThe PTEN Long N-tail is intrinsically disordered: increased viability for PTEN therapySustained proliferation in cancer: Mechanisms and novel therapeutic targetsResveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor.Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network.Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice.Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibitionResveratrol induces long-lasting IL-8 expression and peculiar EGFR activation/distribution in human keratinocytes: mechanisms and implications for skin administration.Natural products as potential cancer therapy enhancers: A preclinical update.Structure-based virtual screening and identification of a novel androgen receptor antagonist.A Module Analysis Approach to Investigate Molecular Mechanism of TCM Formula: A Trial on Shu-feng-jie-du Formula.ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases.PTEN mediates the antioxidant effect of resveratrol at nutritionally relevant concentrations.Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway.Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals.Multivalent Peptoid Conjugates Which Overcome Enzalutamide Resistance in Prostate Cancer Cells.Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer.Transcription factor KLLN inhibits tumor growth by AR suppression, induces apoptosis by TP53/TP73 stimulation in prostate carcinomas, and correlates with cellular differentiationPTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade.Biological Mechanisms by Which Antiproliferative Actions of Resveratrol Are Minimized.Regulation of the tumor suppressor PTEN by natural anticancer compounds.The Role of Resveratrol in Cancer Therapy.Implications of Bcl-2 and its interplay with other molecules and signaling pathways in prostate cancer progression.Impact of Phytochemicals and Dietary Patterns on Epigenome and Cancer.Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer.Resveratrol in spermatogenesis.PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications
P2860
Q24601444-4959DDBA-4FEA-4798-ADA9-65F1E0AAB6A3Q24618313-A550FADA-45DD-4F90-A43B-2808D264FECBQ28084787-644AC842-B760-4778-8482-2BC171D250B6Q28299026-7A37A92D-7799-46D8-84E5-1C004D19001DQ28396388-3963FBB7-F045-4760-BD77-38C928136233Q30994649-B3920B0A-503F-461B-B02F-3FFAFE831244Q34271192-E4660A66-E208-4EBA-B19C-72826F4F2169Q34539310-2473ACD4-3B98-49D3-8D43-047B43A84479Q34571639-653952F0-999B-4B20-98FE-297555B24655Q34635356-2FE5BDEC-4594-4E18-AC01-66700716DE49Q36165835-DC81649B-A9FB-4E6E-83C4-BF2277CFF2A3Q36216496-FBF7182C-BCA9-4765-804B-0A1C681EE45AQ37385774-29D647B0-BE83-41DD-9356-6BF7491B9D95Q37668848-62C920CD-9DB5-48F8-B48C-1AF8D056672CQ37725464-78DD1019-99D2-47DB-ADCF-413562FCEE4CQ37725595-31BFB36F-A4A1-4B78-ACF3-644DCC0074AFQ38269745-DB7A90DF-131A-452F-8F2A-A462081CAF04Q38753981-AEB712FD-765B-43F7-9287-E86C21C2DDB7Q38839803-02580DEB-032A-4509-83AB-8AB3883AE41AQ42148183-9D0E3B10-05D2-4C21-A60B-5FE6B8A72D9EQ45359397-50565AB6-767A-4F43-9FA6-18CBEAFA0A1DQ46752370-D2DF313D-CA2B-499E-B810-DEFA80995F06Q47691876-76C4D2EC-CCAB-46EC-817B-71A579E6C1B0Q47940580-1AC24C66-897B-45D5-8E65-60DD624750A1Q47941645-5F8D0EC4-E416-4024-9AE0-74DA8D03F511Q51187064-7CCC54E0-80E0-4460-96B2-B612B92FE68AQ52870570-9EA0A937-0FCE-4AF0-BCEA-7CC45F6DB428Q52966725-BCFC9645-3898-4613-998E-8E7CABB769D6Q57790325-40209D61-099B-497E-A000-8F8B352BD706
P2860
Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Resveratrol regulates the PTEN ...... in prostate cancer cell lines.
@en
Resveratrol regulates the PTEN ...... in prostate cancer cell lines.
@nl
type
label
Resveratrol regulates the PTEN ...... in prostate cancer cell lines.
@en
Resveratrol regulates the PTEN ...... in prostate cancer cell lines.
@nl
prefLabel
Resveratrol regulates the PTEN ...... in prostate cancer cell lines.
@en
Resveratrol regulates the PTEN ...... in prostate cancer cell lines.
@nl
P2093
P2860
P356
P1476
Resveratrol regulates the PTEN ...... in prostate cancer cell lines.
@en
P2093
Mohammed S Orloff
Robert H Silverman
Todd Romigh
Warren D Heston
P2860
P304
P356
10.1093/HMG/DDQ354
P50
P577
2010-08-20T00:00:00Z